News

Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Public Broadcasting Service (PBS)1h
FDA approves Novavax COVID-19 vaccine, but with unusual restrictions on its use
In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about ...
Daily Times on MSN10h
FDA approves Novavax covid vaccine with limits on eligibility
The US Food and Drug Administration (FDA) has approved Novavax's Covid-19 vaccine, Nuvaxovid, but only for limited use in ...
US FDA approves Novavax COVID-19 vaccine with new conditions
According to approval letter, the license restricts the use of vaccine called Nuvaxovid to individuals aged 65 and older, and ...
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
F.D.A. Approves Novavax Covid Vaccine With Stricter New Conditions
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
FDA approves Novavax COVID-19 shot but with unusual restrictions
WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with ...
Pfizer scientist claimed COVID vax results being delayed until after 2020 election ‘wasn’t a coincidence’: House GOP panel
The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.